NYSE: LLY
Eli Lilly & Co.
$1,364.73▼ -3.76%Thursday, Nov 5 close · data delayed
Past 90 trading days
- 30-day change
- ▲ +15.73%
- 90-day high
- $1,417.99
- 90-day low
- $1,115.68
- Avg volume (20d)
- 2.9M
- Market cap
- $1.27T
- 52-week high
- $1,453.00
- 52-week low
- $623.78
Bellwize coverage
Earnings
Eli Lilly Climbs as Mounjaro and Zepbound Drive a 39% Revenue JumpThe drugmaker's third-quarter sales rose 39% and it lifted its full-year revenue outlook by more than $5 billion, sending the stock higher in Thursday afternoon trading.
Oct 29, 2026, 2:41 PM ET
Stocks
Eli Lilly's Obesity Combo Beats Tirzepatide in a Study as Shares Erase an Early PopA midstage trial showed the company's eloraTZP combination cut weight by 23.3% against 14.8% for tirzepatide alone, though dropout rates ran higher and the stock gave back a morning gain.
Sep 30, 2026, 1:45 PM ET
Stocks
Eli Lilly Slips as It Buys Merida Biosciences in a $2.9 Billion Autoimmune DealLilly agreed to pay up to $2.88 billion in cash for a private biotech developing antibody therapies for autoimmune and allergic disease, and its shares eased in afternoon trading.
Aug 31, 2026, 1:37 PM ET
Company resources
This is a general-market summary for information only — not investment advice, and not a recommendation regarding any security.